| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cerus Corporation (NASDAQ: CERS)
CERS Technical Analysis
5
| As on 9th Jun 2023 CERS SHARE Price closed @ 2.52 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.96 & Strong Sell for SHORT-TERM with Stoploss of 5.82 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CERSSHARE Price
| Open | 2.54 | Change | Price | % |
| High | 2.62 | 1 Day | -0.01 | -0.40 |
| Low | 2.50 | 1 Week | 0.59 | 30.57 |
| Close | 2.52 | 1 Month | 0.09 | 3.70 |
| Volume | 1229605 | 1 Year | -4.17 | -62.33 |
| 52 Week High 6.99 | 52 Week Low 1.79 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CERS Daily Charts |
CERS Intraday Charts |
Whats New @ Bazaartrend |
CERS Free Analysis |
|
|
CERS Important Levels Intraday
| RESISTANCE | 2.75 |
| RESISTANCE | 2.68 |
| RESISTANCE | 2.63 |
| RESISTANCE | 2.59 |
| SUPPORT | 2.45 |
| SUPPORT | 2.41 |
| SUPPORT | 2.36 |
| SUPPORT | 2.29 |
CERS Forecast April 2024
| 4th UP Forecast | 6.24 |
| 3rd UP Forecast | 5.05 |
| 2nd UP Forecast | 4.31 |
| 1st UP Forecast | 3.57 |
| 1st DOWN Forecast | 1.47 |
| 2nd DOWN Forecast | 0.73 |
| 3rd DOWN Forecast | -0.01 |
| 4th DOWN Forecast | -1.2 |
CERS Weekly Forecast
| 4th UP Forecast | 3.21 |
| 3rd UP Forecast | 2.99 |
| 2nd UP Forecast | 2.85 |
| 1st UP Forecast | 2.72 |
| 1st DOWN Forecast | 2.32 |
| 2nd DOWN Forecast | 2.19 |
| 3rd DOWN Forecast | 2.05 |
| 4th DOWN Forecast | 1.83 |
CERS Forecast2024
| 4th UP Forecast | 12.77 |
| 3rd UP Forecast | 9.48 |
| 2nd UP Forecast | 7.45 |
| 1st UP Forecast | 5.42 |
| 1st DOWN Forecast | -0.38 |
| 2nd DOWN Forecast | -2.41 |
| 3rd DOWN Forecast | -4.44 |
| 4th DOWN Forecast | -7.73 |
Cerus Corporation ( NASDAQ USA Symbol : CERS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CERS Business Profile
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation has collaboration with LifeSouth Community Blood Centers to manufacture INTERCEPT Fibrinogen Complex. The company was incorporated in 1991 and is headquartered in Concord, California. Address: 1220 Concord Avenue, Concord, CA, United States, 94520
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service